Table 6.
Stepwise Multivariate Analysis for All Classes of Clavien-Dindo Complications Versus Patient Demographics, Comparing Demographics Across Mesh Type, Component Separation (Closure Type), and Demographics Combined With Mesh Type and Closure Type
| Complication | No | Yes | OR (Univariable) | Demographics | Demographics and Mesh Type | Demographics and Closure Type | Demographics, Mesh Type, and Closure Type |
|---|---|---|---|---|---|---|---|
| OR (Multivariable) | OR (Multivariable) | OR (Multivariable) | OR (Multivariable) | ||||
| P4HB, N (%) | 25 (52.1) | 6 (24.0) | 0.291 (0.099–0.854, P = 0.025) | 0.128 (0.028–0.582, P = 0.008) | 0.081 (0.015–0.437, P = 0.003) | ||
| Component separation (%) | 12 (0.25) | 7 (0.28) | 1.167 (0.392–3.471, P = 0.782) | 1.655 (0.415–6.600, P = 0.475) | 4.314 (0.762–24.410, P = 0.098) | ||
| Mean age, years (SD) | 55.9 (12.7) | 53.8 (10.8) | 0.985 (0.945–1.026), P = 0.479) | 1.013 (0.956–1.074, P = 0.659) | 1.020 (0.957–1.087, P = 0.546) | 1.011 (0.122–2.387, P = 0.720) | 1.009 (0.944–1.078, P = 0.794) |
| Gender, n (%) | 33 (68.8) | 17 (68.0) | 0.966 (0.342–2.729, P = 0.948) | 0.583 (0.134–2.532, P = 0.471) | 0.839 (0.166–4.250, P = 0.832) | 0.541 (0.122–2.387, P = 0.417) | 0.789 (0.154–4.036, P = 0.776) |
| African American, N (%) | 11 (22.9) | 10 (40.0) | 2.242 (0.788–6.380, P = 0.130) | 8.627 (1.860–40.024, P = 0.006) | 13.157 (2.352–73.609, P = 0.003) | 8.745 (1.844–41.478, P = 0.006) | 14.595 (2.386–89.278, P = 0.004) |
| BMI (kg/m2), N (%) | 30.3 (6.0) | 32.2 (8.2) | 1.04 (0.969–1.116, P = 0.275) | 1.096 (0.992–1.211, P = 0.073) | 1.094 (0.979–1.222, P = 0.111) | 1.103 (0.996–1.221, P = 0.059) | 1.118 (0.994–1.259, P = 0.064) |
| Hypertension (%) | 37 (77.1) | 18 (72.0) | 0.764 (0.254–2.302, P = 0.633) | 0.537 (0.123–2.344, P = 0.409) | 0.527 (0.118–2.357, P = 0.402) | 0.527 (0.118–2.359, P = 0.402) | 0.501 (0.100–2.501, P = 0.400) |
| Diabetes (%) | 17 (35.4) | 8 (32.0) | 0.858 (0.307–2.398, P = 0.770) | 0.658 (0.177–2.441, P = 0.531) | 0.400 (0.090–1.779, P = 0.229) | 0.674 (0.181–2.505, P = 0.556) | 0.386 (0.084–1.769, P = 0.220) |
| Alcohol use, N (%) | 13 (27.1) | 10 (40.0) | 1.744 (0.626–4.855, P = 0.287) | 3.285 (0.784–13.771, P = 0.104) | 5.474 (1.072–27.952, P = 0.041) | 3.277 (0.769–13.968, P = 0.109) | 5.944 (1.059–33.352, P = 0.043) |
| Smoker, N (%) | 21 (43.8) | 17 (68.0) | 2.732 (0.99–7.543, P = 0.052) | 6.709 (1.727–26.063, P = 0.006) | 8.279 (1.915–35.786, P = 0.005) | 7.207 (1.796–28.917, P = 0.005) | 10.073 (2.101–48.300, P = 0.004) |
| Liver disease, N (%) | 26 (54.2) | 12 (48.0) | 0.781 (0.297–2.057, P = 0.617) | 0.725 (0.177–2.978, P = 0.656) | 0.400 (0.077–2.093, P = 0.278) | 0.776 (0.188–3.200, P = 0.725) | 0.409 (0.078–2.137, P = 0.290) |
| Immunocompromised, N (%) | 28 (58.3) | 14 (56.0) | 0.909 (0.343–2.413, P = 0.848) | 1.662 (0.466–5.930, P = 0.433) | 1.816 (0.452–7.299, P = 0.400) | 1.536 (0.420–5.621, P = 0.516) | 1.621 (0.378–6.958, P = 0.516) |
BMI indicates body mass index.